MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

Abroad (travel likely)Recruiting

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sunnybrook Health Science Centre, Toronto, Ontario, Canada
Contact: Study coordinator (Katarzyna Jerzak, MD M.Sc) · katarzyna.jerzak@sunnybrook.ca · 416-480-6100

Study leads

Katarzyna Jerzak, MD, M.Sc
Principal Investigator
Sunnybrook Health Sciences Centre

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

Female Breast Cancer · Prostate Cancer · Colorectal Carcinoma

Abroad (travel likely)Recruiting

Detroit, United States

A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.

Advanced Breast Cancer Brain Metastasis

Abroad (travel likely)Recruiting

Beijing, China

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

Breast Cancer

Abroad (travel likely)Recruiting

Chapel Hill, United States

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Breast Cancer · Quality of Life

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States